Accuray, Inc. (ARAY)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$0.12-16.90%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · ARAY
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers · Company calendar date is not available
ARAY — dividend update
Dated 2026-11-04
Other Events. As previously disclosed, at the 2026 Special Meeting of Stockholders of Accuray Incorporated (the “Company”) held on October 6, 2026 (the “2026 Special Meeting”), the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”) to effect a reverse stock split with a ratio ranging from any whole number between 1-for-15 and 1-for-40, as determined by the Board of Directors (the “Boa…
Why it matters: FY26 product revenue fell 27%, and Q4 orders fell 55%. A rebound would ease concern about weak demand.
Watch forOn the Nov. 4 earnings report, product revenue rises year over year and gross product orders exceed $37.7 million.
Also watch forProduct revenue falls year over year again, or gross product orders stay below $37.7 million.
Why it matters: Backlog fell 27% year over year by FY26 year-end, and Q4 book-to-bill was 0.9. Further declines could point to weaker future sales.
Worry ifBacklog falls below $312.5 million, or book-to-bill stays below 1.0 in the next report.
Less concerning ifBacklog rises above $312.5 million and book-to-bill reaches at least 1.0.
Why it matters: Q3 gross margin fell to 24.1% as parts use, shipping, and duties costs rose. Lower costs could help margins recover.
Watch forGross margin rises above the FY26 level of 27.7%, with lower parts, shipping, or duty costs reported.
Also watch forGross margin falls below 27.7%, or the company reports continued high parts, shipping, or duty costs.
Why it matters: The deal includes $15 million in new equity and covenant relief through Dec. 31, 2027. Completion would add cash and time.
Supportive ifAn 8-K or company release confirms the TCW deal closed. It includes the $15 million equity investment and covenant relief.
Worry ifThe company reports that the TCW deal did not close, or that key funding terms were changed or withdrawn.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$341 on $10,000 · ±3.4% | How much price usually moves either way. |
| Bad day | $1,037 loss on $10,000 · 10.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,151 loss on $10,000 · 91.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Stockholders approved a 1-for-15 to 1-for-40 split. The board has not set its ratio or timing.
Watch forThe board names a split ratio within 1-for-15 to 1-for-40 and gives an effective date.
Also watch forThe board states it will not use the approved split, or no split date is set by the next reported quarter.